QNCX SCHEDULE 13G/A: SEC filing

Balyasny Asset Management L.P. and affiliated reporting persons

Filed with the SEC on · accession 0001172661-26-005046

QNCX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Balyasny Asset Management L.P. and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of approximately 9.99% of IRulya Therapeutics Inc. common stock, consisting of 69,281 shares and 32,323 shares issuable upon exercise of warrants and preferred shares,…

Summary of the filing

Balyasny Asset Management L.P. and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of approximately 9.99% of IRulya Therapeutics Inc. common stock, consisting of 69,281 shares and 32,323 shares issuable upon exercise of warrants and preferred shares, subject to a 9.99% beneficial ownership blocker.

Key details

Shares beneficially ownedshares 102K
Shares outstanding as of Aug. 7, 2026shares 1.0M
Reporting person / investment managerBalyasny Asset Management L.P.
IssuerIRulya Therapeutics Inc.
Direct holder of 69,281 sharesAtlas Diversified Master Fund, Ltd.
Direct holder of preferred shares and warrantsAtlas Private Holdings (Cayman) Ltd
Direct holder of preferred shares and warrantsAtlas Private Holdings VIII, LLC
Direct holder of preferred shares and warrantsAEF Plus Privates Fund, LLC
Managing member of dames gp llcDmitry Balyasny
Authorized signatoryScott Schroeder

✦ Ask GOAX AI about this filing — what it means for QNCX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for QNCX?

Click here

Frequently asked questions

What did QNCX file with the SEC on Nov 16, 2026?

QNCX filed a SCHEDULE 13G/A (SEC filing). Balyasny Asset Management L.P. and affiliated reporting persons filed an amended Schedule 13G indicating beneficial ownership of approximately 9.99% of IRulya Therapeutics Inc. common stock, consisting of 69,281 shares and 32,323 shares issuable upon exercise of warrants and preferred shares, subject to a 9.99% beneficial ownership blocker.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other QNCX SEC filings

Get alerts when QNCX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days